GENRX LINEZOLID linezolid 600 mg tablet blister pack

Active ingredient:

linezolid, Quantity: 600 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Linezolid

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: magnesium stearate; hypromellose; macrogol 8000; crospovidone; methylcellulose; titanium dioxide; hyprolose; silicon dioxide

Administration route:

Oral

Units in package:

10

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Linezolid (intravenous or oral) is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species. It is active against Gram-positive bacteria only and has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram-negative pathogen is documented or suspected.

Product summary:

Visual Identification: White coloured, oval shaped, biconvex, film-coated tablet with "APO" engraved on one side and "LIN600" on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Licence status A

Authorization date:

2014-01-31